Phyathai-Paolo Hospital Group launches AI platform to assist doctors in treating complex patients for the first time in Thailand
The Phyathai and Paolo Hospital Group has announced the launch of "Addwise Comorbid," an intelligent technology platform designed to assist doctors in caring for patients with multiple underlying conditions. This represents a new form of medical innovation introduced for the first time in Thailand, aimed at elevating treatment standards to be more precise and safer.
Currently, many patients suffer from complications or multiple underlying diseases, which makes treatment difficult and high-risk. The Addwise Comorbid platform was developed to help analyze patient health data in detail. The system processes information on medication usage and medical history to prevent potential drug interactions that could be harmful to patients.
Beyond reducing treatment errors, this system allows doctors to plan treatments more quickly and efficiently. Doctors can access patient insights in real-time, which reduces diagnostic time and ensures that patients receive care that is truly tailored to their individual physical conditions.
Integrating artificial intelligence (AI) into the Thai public health system marks a significant step in the transition toward the digital medical era. This not only helps alleviate the burden on medical personnel but also provides assurance to patients that they will receive high-quality, safe services that meet international standards.
In the future, the Phyathai and Paolo Hospital Group plans to continuously develop this platform to support the care of patients with increasingly complex conditions. They hope this innovation will serve as a key model for advancing and modernizing Thailand's medical system.